-
サマリー
あらすじ・解説
This article argues that strategic outsourcing, particularly for Small Molecule APIs, is a key component of successful drug development. It outlines the benefits of outsourcing for pharmaceutical companies, including cost reduction, increased focus on R&D, and faster time-to-market. The article also emphasizes the importance of regulatory strategy and highlights how Enkrisi, a company specializing in drug development consulting, can help pharmaceutical companies navigate complex regulatory requirements. The article concludes by presenting case studies demonstrating the successful implementation of outsourcing strategies for various pharmaceutical companies.
Support the show